1. The present role of α-adrenergic blockers in the treatment of benign prostatic hypertrophy;Caine;J Urol,1986
2. Pathophysiology of clinical benign prostatic hyperplasia;Shapiro;Urol Clin North Am,1995
3. RO700004, a selective α1a-adrenoceptor antagonist, does not improve lower urinary tract symptoms in men with benign prostatic hyperplasia;Blue;J Urol,2002
4. Does sexual equality extend to urinary symptoms?;Jollys;Neurourol Urodyn,1993
5. Urinary symptoms and urodynamics in a normal elderly population;Homma;Scand J Urol Nephrol,1994